iFlourish Labs, LLC – Trademark Portfolio

Entity Type: 16

iFlourish Labs, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IFLOURISH LABS. The owner is based in Springfield, OR.

1970 28th St.

Springfield, OR 97477

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

iFlourish Labs, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (1 filing)

Clothing, footwear, headgear

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does iFlourish Labs, LLC have?

iFlourish Labs, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does iFlourish Labs, LLC file in?

iFlourish Labs, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are iFlourish Labs, LLC's most well-known trademarks?

iFlourish Labs, LLC's registered trademark portfolio includes well-known marks such as IFLOURISH LABS. These are among 2 currently registered trademarks in the portfolio.

What is iFlourish Labs, LLC's trademark registration success rate?

iFlourish Labs, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.